SEC Form 4 · accession 0001209191-15-019059
Auspex Pharmaceuticals, Inc. · ASPX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Feb 24, 2015
Accepted (ET)
Feb 26, 2015 · 4:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001454189
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 24, 2015 | J | 195,000 | $0.00 | D | 2,770,521 | D | |
| Common Stock | Feb 24, 2015 | J | 5,000 | $0.00 | D | 71,089 | I | By: CMEA Ventures VII (Parallel) LP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1CMEA Ventures VII, L.P. made a pro rata distribution for no consideration of an aggregate of 195,000 shares of Common Stock of the Issuer to its general partner and its limited partners on February 24, 2015.
- F2CMEA Ventures VII (Parallel), L.P. made a pro rata distribution for no consideration of an aggregate of 5,000 shares of Common Stock of the Issuer to its general partner and its limited partners on February 24, 2015.